{"entity":{"type":"insider","cik":"0001472322","url":"/insider/0001472322","json_url":"/insider/0001472322.json","name":"Nantahala Capital Management, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":3,"first":"2012-04-24","last":"2025-01-30","span_basis":"filed_date"},"name_variants":[{"name":"Nantahala Capital Management, LLC","source":"filing","n_filings":3,"first_seen":"2012-04-24","last_seen":"2025-01-30"}],"transactions":[{"id":4986223,"accession":"0001104659-25-007682","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-007682","line_url":"/filing/0001104659-25-007682#line-1","is_derivative":false,"issuer_cik":"0001403708","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001403708","owner_cik":null,"owner_name":"Harkey Wilmot B.; Mack Daniel; Nantahala Capital Management, LLC","owner_display_name":"Harkey Wilmot B.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41.0,"shares_display":"41","price_per_share":4.3871,"price_display":"4.39","price_state":"stated","total_value":179.8711,"total_display":"179.87","total_whole":"180","shares_owned_after":148153.0,"shares_owned_after_display":"148,153","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-01-28","filed_date":"2025-01-30","scope":"insider"},{"id":7824114,"accession":"0001144204-19-031161","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-19-031161","line_url":"/filing/0001144204-19-031161#line-2","is_derivative":false,"issuer_cik":"0001472322","issuer_name":"FTD Companies, Inc.","issuer_ticker":"FTD","issuer_name_source":null,"issuer_url":"/issuer/0001472322","owner_cik":null,"owner_name":"Harkey Wilmot B.; Nantahala Capital Management, LLC; Mack Daniel","owner_display_name":"Harkey Wilmot B.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":710763.0,"shares_display":"710,763","price_per_share":0.039,"price_display":"0.04","price_state":"stated","total_value":27719.757,"total_display":"27,719.76","total_whole":"27,720","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-14","filed_date":"2019-06-17","scope":"insider"},{"id":7824111,"accession":"0001144204-19-031161","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-19-031161","line_url":"/filing/0001144204-19-031161#line-1","is_derivative":false,"issuer_cik":"0001472322","issuer_name":"FTD Companies, Inc.","issuer_ticker":"FTD","issuer_name_source":null,"issuer_url":"/issuer/0001472322","owner_cik":null,"owner_name":"Harkey Wilmot B.; Nantahala Capital Management, LLC; Mack Daniel","owner_display_name":"Harkey Wilmot B.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000000.0,"shares_display":"3,000,000","price_per_share":0.046,"price_display":"0.05","price_state":"stated","total_value":138000.0,"total_display":"138,000.00","total_whole":"138,000","shares_owned_after":710763.0,"shares_owned_after_display":"710,763","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-13","filed_date":"2019-06-17","scope":"insider"},{"id":2120776,"accession":"0001144204-12-023548","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001144204-12-023548","line_url":"/filing/0001144204-12-023548#line-5","is_derivative":false,"issuer_cik":"0001365216","issuer_name":"Sucampo Pharmaceuticals, Inc.","issuer_ticker":"SCMP","issuer_name_source":null,"issuer_url":"/issuer/0001365216","owner_cik":"0001472322","owner_name":"Nantahala Capital Management, LLC","owner_display_name":"Nantahala Capital Management, LLC","owner_url":"/insider/0001472322","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":124389.0,"shares_display":"124,389","price_per_share":8.2511,"price_display":"8.25","price_state":"stated","total_value":1026346.0779,"total_display":"1,026,346.08","total_whole":"1,026,346","shares_owned_after":371662.0,"shares_owned_after_display":"371,662","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-04-23","filed_date":"2012-04-24","scope":"insider"},{"id":2120773,"accession":"0001144204-12-023548","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-12-023548","line_url":"/filing/0001144204-12-023548#line-4","is_derivative":false,"issuer_cik":"0001365216","issuer_name":"Sucampo Pharmaceuticals, Inc.","issuer_ticker":"SCMP","issuer_name_source":null,"issuer_url":"/issuer/0001365216","owner_cik":"0001472322","owner_name":"Nantahala Capital Management, LLC","owner_display_name":"Nantahala Capital Management, LLC","owner_url":"/insider/0001472322","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61891.0,"shares_display":"61,891","price_per_share":8.2511,"price_display":"8.25","price_state":"stated","total_value":510668.8301,"total_display":"510,668.83","total_whole":"510,669","shares_owned_after":275640.0,"shares_owned_after_display":"275,640","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-04-23","filed_date":"2012-04-24","scope":"insider"},{"id":2120768,"accession":"0001144204-12-023548","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-12-023548","line_url":"/filing/0001144204-12-023548#line-3","is_derivative":false,"issuer_cik":"0001365216","issuer_name":"Sucampo Pharmaceuticals, Inc.","issuer_ticker":"SCMP","issuer_name_source":null,"issuer_url":"/issuer/0001365216","owner_cik":"0001472322","owner_name":"Nantahala Capital Management, LLC","owner_display_name":"Nantahala Capital Management, LLC","owner_url":"/insider/0001472322","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33620.0,"shares_display":"33,620","price_per_share":8.2511,"price_display":"8.25","price_state":"stated","total_value":277401.982,"total_display":"277,401.98","total_whole":"277,402","shares_owned_after":97788.0,"shares_owned_after_display":"97,788","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-04-23","filed_date":"2012-04-24","scope":"insider"},{"id":2120765,"accession":"0001144204-12-023548","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-12-023548","line_url":"/filing/0001144204-12-023548#line-2","is_derivative":false,"issuer_cik":"0001365216","issuer_name":"Sucampo Pharmaceuticals, Inc.","issuer_ticker":"SCMP","issuer_name_source":null,"issuer_url":"/issuer/0001365216","owner_cik":"0001472322","owner_name":"Nantahala Capital Management, LLC","owner_display_name":"Nantahala Capital Management, LLC","owner_url":"/insider/0001472322","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":0.0,"shares_display":"0","price_per_share":8.2511,"price_display":"8.25","price_state":"stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":438234.0,"shares_owned_after_display":"438,234","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-04-23","filed_date":"2012-04-24","scope":"insider"},{"id":2120761,"accession":"0001144204-12-023548","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-12-023548","line_url":"/filing/0001144204-12-023548#line-1","is_derivative":false,"issuer_cik":"0001365216","issuer_name":"Sucampo Pharmaceuticals, Inc.","issuer_ticker":"SCMP","issuer_name_source":null,"issuer_url":"/issuer/0001365216","owner_cik":"0001472322","owner_name":"Nantahala Capital Management, LLC","owner_display_name":"Nantahala Capital Management, LLC","owner_url":"/insider/0001472322","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":0.0,"shares_display":"0","price_per_share":8.2511,"price_display":"8.25","price_state":"stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":231037.0,"shares_owned_after_display":"231,037","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-04-23","filed_date":"2012-04-24","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001403708","name":"Evoke Pharma Inc","url":"/issuer/0001403708","role":"Ten percent owner","n_filings":1,"first_seen":"2025-01-30","last_seen":"2025-01-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001575360","name":"FTD Companies, Inc.","url":"/issuer/0001575360","role":"Ten percent owner","n_filings":1,"first_seen":"2019-06-17","last_seen":"2019-06-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001365216","name":"Sucampo Pharmaceuticals, Inc.","url":"/issuer/0001365216","role":"Ten percent owner","n_filings":1,"first_seen":"2012-04-24","last_seen":"2012-04-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001472322","retrieved_at":"2026-08-25T07:15:40+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}